MINNEAPOLIS, March 20, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the Company”), America’s leading science-focused multi-state cannabis company, is pleased to announce that effective at market open today, the company will begin trading on the Canadian Securities Exchange (the “CSE”) under the ticker symbol “VREO.”
Today is an historic milestone for Vireo Health, our business and product offerings are expanding rapidly, and we expect the proceeds from our RTO transaction will enable us to significantly expand our geographic footprint and our investments in intellectual property development.
Chief Executive Officer, Kyle Kingsley, M.D.
We are proud of our track record of creating value for shareholders over time, and our board of directors and executive management team will continue to prioritize this important goal as we transition to operating as a public company.
“We believe that science will drive the lion’s share of long-term opportunity in the cannabis industry. From novel, efficient, scaled processing equipment, to proprietary consumer products and our expansive intellectual property portfolio, Vireo has positioned itself as the cannabis company of the future,” Dr. Kingsley said.
Dr. Kingsley continued, “Vireo has been pursuing a business model consistent with this vision since its inception, and our leadership team is committed to achieving this objective. We also believe that customer service excellence will be key toward winning and maintaining market share, and we look forward to leveraging our proprietary e-commerce and home delivery platforms to meet the highly-demanding needs of today’s modern consumer landscape.”
In conjunction with the previously-announced business combination with Darien Business Development Corp., Vireo Health International, Inc. raised more than US $50 million through a brokered and non-brokered private placement offering. Concurrent with the public listing, the Company launched its new investor relations website at investors.vireohealth.com.
About Vireo Health International, Inc.
Vireo Health International, Inc. is America’s leading science-focused, multi-state cannabis company. Vireo’s physician-led team of more than 250 employees is dedicated to providing best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently has operations in six states including Minnesota, New York, Pennsylvania, Maryland, Rhode Island, and Ohio.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.